Table 2.
Cox regression analysis for prognosticators in BRCA patients based on TCGA database. CI, confidence interval; HR, hazard ratio.
Variables | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
P‐value | HR | 95% CI | P‐value | HR | 95% CI | |
CHPF expression (high/low) | 0.016* | 1.541 | 1.083–2.194 | 0.084 | 1.375 | 0.958–1.972 |
Pathologic stage (I + II/III + IV) | 0.000* | 2.789 | 1.953–3.983 | 0.023* | 1.913 | 1.092–3.353 |
Pathologic‐T (T1 + T2/T3 + T4) | 0.001* | 1.920 | 1.293–2.851 | 0.824 | 0.943 | 0.562–1.582 |
Pathologic M (M0/M1) | 0.000* | 6.362 | 3.569–11.339 | 0.010* | 2.384 | 1.236–4.598 |
Pathologic N (N0/N1 + N2 + N3) | 0.000* | 2.133 | 1.471–3.093 | 0.055 | 1.563 | 0.990–2.466 |
Age (< 60/≥ 60) | 0.000* | 2.002 | 1.402–2.859 | 0.000* | 2.032 | 1.407–2.935 |
Gender (female/male) | 0.877 | 0.856 | 0.119–6.137 |
P < 0.05.